Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
filingDate |
2004-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f8f13ae2bc1605d4145cfe66b0446ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_647751de468627e40a206ab6145281bc |
publicationDate |
2005-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2005037063-A1 |
titleOfInvention |
Combined therapies |
abstract |
This invention provides a combination treatment and compositions for alleviating the symptoms of a cardiovascular disorder in a mammalian patient, which comprises administration to the patient of an effective amount of synthetic and/or semi-synthetic bodies carrying phospholipid ligands on their surfaces, said bodies have a size of from about 20 nanometers to about 500 microns; and an effective amount of a cardiovascular drug. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013202680-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9757398-B2 |
priorityDate |
2003-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |